Abstract:Vascular endothelial cells produce various biologically active factors regulating blood pressure, coagulation, and possibly cell growth of the vascular wall. Of the factors, nitric oxide (NO) has been the object of attention because of its quite simple molecular structure and variety of biological functions. In the present review, we focused on the physiologic and pathologic aspects of NO in hypertension. In experimental animals, both acute and chronic inhibition of NO synthase (NOS) with arginine derivatives produce a significant rise in blood pressure, indicating that tonic production of NO regulates basal vascular tonus. The chronic hypertension caused by NOS inhibitor is associated with cardiac hypertrophy and renal insufficiency. Sodium retention, though transient, and the plasma and tissue renin/angiotensin system in addition to the reduced production of NO have been implicated in the development of hypertension. Hypertension and the associated target organ failure can be reversed by co-administration of L-arginine or blockades of the renin/angiotensin system. Studies in which L-arginine as the substrate of NO or NOS inhibitor was administered demonstrated an important role of NO in the regulation of tonic vascular tonus also in normal subjects. In hypertensive subjects, however, endothelium-dependent vasorelaxation and production of NO are impaired, possibly due to a deficiency of L-arginine and/or a disorder of its utilization. Recent advances in the methods of detecting NO enabled us to demonstrate its diminished production from endothelial cells of hypertensive rats in vitro, although no definite biochemical evidence has been obtained in hypertensive subjects. The endothelial dysfunction, however, is not a primary cause of hypertension but a secondary result since it is commonly observed in various types of hypertension and can be reversed by correcting the blood pressure. Other common diseases including atherosclerosis and diabetes mellitus are also associated with similar abnormalities of the endothelium. NO has anti-atherogenic actions: inhibition of platelet functions and proliferation of vascular smooth muscle cells. Therefore, potentiation of endogenous NO and/or supplement of exogenous NO donors could be novel therapeutic approaches for the treatment of hypertension and atherosclerosis, while potential adverse effects of NO including cytotoxicity, immunosuppressibility, and hypotensive shock should be taken into account.

The Effects of Oral l-Arginine and l-Citrulline Supplementation on Blood Pressure

Effect of Oral L-Arginine Supplementation on Blood Pressure: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials

l-Citrulline Supplementation: Impact on Cardiometabolic Health

Clinical Studies of L-Arg Effect on Essential Hypertension

Vascular effects of dietary l-arginine supplementation

Assessment of Registered Clinical Trial Designs: Comparison of L-Arginine and/or L-Citrulline Interventions for Hypertension

Effect of Oral L-citrulline on Brachial and Aortic Blood Pressure Defined by Resting Status: Evidence from Randomized Controlled Trials

[Clinical significance of nitric oxide in hypertension]

Impact of L‐citrulline on nitric oxide signaling and arginase activity in hypoxic human pulmonary artery endothelial cells

The potential of stimulating nitric oxide formation in the treatment of hypertension

Short-Term Supplementation of Sodium Nitrate vs. Sodium Chloride Increases Homoarginine Synthesis in Young Men Independent of Exercise

Arginine and Endothelial Function

509 L-CITRULLINE SUPPLEMENTATION REDUCED PERIPHERAL BLOOD PRESSURE IN CHINESE ADULTS WITH PREHYPERTENSION

L-citrulline as Alternative Pharmacological Substance in Protecting Against Cardiovascular Disease

Dietary Arginine and Citrulline Supplements for Cardiovascular Health and Athletic Performance: A Narrative Review

Dose-related effect of intravenous L-arginine on muscular blood flow of the calf in patients with peripheral vascular disease: a H215O positron emission tomography study

Effects of dietary inorganic nitrate on blood pressure during and post exercise: A systematic review and meta-analysis of randomized placebo-controlled trials

The Effectiveness of L-arginine in Clinical Conditions Associated with Hypoxia

Inter-individual responses to arginine oral supplementation on post-exercise hypotension in treated hypertensives: A pilot study

Plasma Metabolome Analysis Suggests That L-Arginine Supplementation Affects Microbial Activity Resulting in a Decrease in Trimethylamine N-oxide-A Randomized Controlled Trial in Healthy Overweight Adults with Cardiometabolic Risk Factors